| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 602 | 2023 |
| Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection MJ Peluso, S Lu, AF Tang, MS Durstenfeld, H Ho, SA Goldberg, ... The Journal of infectious diseases 224 (11), 1839-1848, 2021 | 270 | 2021 |
| Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ... Cell Reports 36 (6), 2021 | 207 | 2021 |
| ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study MJ Broadhurst, JD Kelly, A Miller, A Semper, D Bailey, E Groppelli, ... The Lancet 386 (9996), 867-874, 2015 | 194 | 2015 |
| Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations B Sun, N Tang, MJ Peluso, NS Iyer, L Torres, JL Donatelli, SE Munter, ... Cells 10 (2), 386, 2021 | 191 | 2021 |
| Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 K Yin, MJ Peluso, X Luo, R Thomas, MG Shin, J Neidleman, A Andrew, ... Nature Immunology 25 (2), 218-225, 2024 | 183 | 2024 |
| Prone positioning in moderate to severe acute respiratory distress syndrome due to COVID-19: a cohort study and analysis of physiology MC Shelhamer, PD Wesson, IL Solari, DL Jensen, WA Steele, ... Journal of intensive care medicine 36 (2), 241-252, 2021 | 176 | 2021 |
| Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients J Hellmuth, TA Barnett, BM Asken, JD Kelly, L Torres, ML Stephens, ... Journal of neurovirology 27, 191-195, 2021 | 167 | 2021 |
| Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study JD Kelly, C Hartman, J Graham, MA Kallen, TP Giordano Journal of the Association of Nurses in AIDS Care 25 (5), 405-413, 2014 | 159 | 2014 |
| A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection DG Augusto, LD Murdolo, DSM Chatzileontiadou, JJ Sabatino Jr, ... Nature 620 (7972), 128-136, 2023 | 152 | 2023 |
| Chronic viral coinfections differentially affect the likelihood of developing long COVID MJ Peluso, TM Deveau, SE Munter, D Ryder, A Buck, G Beck-Engeser, ... The Journal of clinical investigation 133 (3), 2023 | 151 | 2023 |
| SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ... Science advances 7 (31), eabh3409, 2021 | 144 | 2021 |
| Biosocial approaches to the 2013-2016 Ebola pandemic ET Richardson, MB Barrie, JD Kelly, Y Dibba, S Koedoyoma, PE Farmer Health and human rights 18 (1), 115, 2016 | 116 | 2016 |
| Strengthening health systems while responding to a health crisis: lessons learned by a nongovernmental organization during the Ebola virus disease epidemic in Sierra Leone C Cancedda, SM Davis, KL Dierberg, J Lascher, JD Kelly, MB Barrie, ... The Journal of infectious diseases 214 (suppl_3), S153-S163, 2016 | 114 | 2016 |
| Community trust and the Ebola endgame RS Dhillon, JD Kelly New England Journal of Medicine 373 (9), 787-789, 2015 | 105 | 2015 |
| Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in Sierra Leone: a field evaluation study AE Semper, MJ Broadhurst, J Richards, GM Foster, AJH Simpson, ... PLoS medicine 13 (3), e1001980, 2016 | 102 | 2016 |
| SARS‐CoV‐2 and mitochondrial proteins in neural‐derived exosomes of COVID‐19 MJ Peluso, SG Deeks, M Mustapic, D Kapogiannis, TJ Henrich, S Lu, ... Annals of neurology 91 (6), 772-781, 2022 | 96 | 2022 |
| Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19 AC Apple, A Oddi, MJ Peluso, BM Asken, TJ Henrich, JD Kelly, ... Annals of clinical and translational neurology 9 (2), 221-226, 2022 | 82 | 2022 |
| Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement MJ Peluso, JD Kelly, S Lu, SA Goldberg, MC Davidson, S Mathur, ... Open forum infectious diseases 9 (2), ofab640, 2022 | 80 | 2022 |
| Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection MJ Peluso, HM Sans, CA Forman, AN Nylander, H Ho, S Lu, SA Goldberg, ... Neurology: Neuroimmunology & Neuroinflammation 9 (5), e200003, 2022 | 77 | 2022 |
